 |
|
Use of Pharmacologic Agents for Treatment of Diabetes Mellitus, Dyslipidemia, and Hypertension in Children and Adolescents
Stephen R. Daniels, MD, PhD
Arch Pediatr Adolesc Med. 2009;163(4):389-391.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
Cardiovascular disease is the number one cause of mortality in the adult population of the United States.1 Much of this is due to atherosclerotic cardiovascular disease. Recognition of these facts has led to national guidelines to control risk factors for cardiovascular disease, such as type 2 diabetes mellitus,2 dyslipidemia,3 and hypertension,4 and to the concept that recognition, treatment, and control of risk factors are important to prevent cardiovascular disease morbidity and mortality.2-4 In fact, the decline in cardiovascular disease mortality over the last 50 years has been attributed to both better control of risk factors and better intensive care in the treatment of acute events.5
The more the process of the development of atherosclerotic cardiovascular disease has been studied, the clearer it has become that the process begins in childhood with deposition of arterial fatty streaks and progresses through adolescence into young adulthood with the . . . [Full Text of this Article] AUTHOR INFORMATION
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
RELATED ARTICLE
Prevalence of Antihypertensive, Antidiabetic, and Dyslipidemic Prescription Medication Use Among Children and Adolescents
Joshua N. Liberman, Jan E. Berger, and Meredith Lewis
Arch Pediatr Adolesc Med. 2009;163(4):357-364.
ABSTRACT
| FULL TEXT
|
